Novel evidence on hepatitis B virus infection in dialysis

International Journal of Artificial Organs

Volumn 24, Issue 1, 2001, Pages 8-16

  Fabrizi, F ^a   Martin, P ^a   Lunghi, G ^a   Ponticelli, C ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS INFECTION;

VIRUSES;

DISINFECTANT AGENT;

ARTIFICIAL KIDNEY; DISINFECTION; EXPERIMENTAL MODEL; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAINTENANCE THERAPY; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; VIRUS TRANSMISSION;

EID: 0035109359     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880102400103     Document Type: Review

References (69)

1. Hepatitis B infection: Pathogenesis and management
2. Epidemiology of viral hepatitis in dialysis centers: A national survey
3. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients
4. Misure di profilassi delle infezioni da virus B e C in Lombardia: Dati del Registro Lombardo Dialisi e Trapianto (RLDT)
5. National surveillance of dialysis associated in the United States
6. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units
7. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: A two year follow-up
8. Hepatitis virus infection in haemodialysis patients from Moldavia
9. Hepatitis B and C in hemodialysis patients
10. Nephrology, dialysis and transplantation in Shangai
11. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit
12. Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: Yellow spots on a blank map?
13. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States
14. Hepatitis B surface antigenemia in a chronic hemodialysis program: Lack of influence on morbidity and mortality
15. Hepatitis B associated liver disease in dialysis patients: Role of vaccination
16. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study
17. Hepatitis B infection. A point-prevalence study in US hemodialysis centers
18. Impact of hepatitis B and C virus on kidney transplantation outcome
19. Hepatitis complicating chronic hemodialysis
20. Hemodialysis-associated hepatitis
21. Combined report of regular dialysis and transplantation in Europe
22. Hemodialysis-associated hepatitis in the United States - 1972
23. Control measures for hepatitis type B in dialysis centers
24. Impact of infection control strategies on the incidence of dialysis associated hepatitis in the United States
25. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients
26. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other blood-borne pathogens in healthcare settings
27. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
28. Hepatitis B virus: Genotypes and subtypes in Brazilian hemodialysis patients
29. Outbreaks of hepatitis B virus infection among hemodialysis patients - California, Nebraska, and Texas, 1994
30. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis
31. Preventing hepatitis B and hepatitis C virus infection in endstage renal disease patients: Back to basics
32. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutants
33. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: Evidence for environmental transmission
34. Incident a markerului virusului hepatitei C şi corelatiile sale cu alti parametri la bolnavii hemodializati cronic in perioada 1991-1995 in centrul de hemodializ al Spitalului Clinic de Nefrologi 'Dr Carol Davilla' Bucuresti
35. Infectiile cu virusurile hepatitice S si C la bolnavii cu insuficienta renalacronica tratati cui hemodializa
36. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS5 regions
37. Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences
38. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
39. Comparison of the aminoacid sequence of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains
40. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen
41. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry to precore stop mutant
42. HBs antigen subtypes: Proceedings of the International Worshop of HBs antigen subtypes
43. Distribution of HBsAg subtypes in the world
44. Kinetics of antibody response to hepatitis B virus determinants and to recombinant vaccines in Italy
45. Qualitative analysis of the humoral immune response to the a determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine
46. Prediction of protein antigenic determinants from amino acid sequences
47. Guidelines for the care of patients hospitalized with viral hepatitis
48. Survival of hepatitis B virus after drying and storage for one week
49. Air-rinsing after dialysis. A mode of transmission of hepatitis virus
50. Possible airborne spread of serum-hepatitis virus within a haemodialysis unit
51. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit
52. A common-source outbreak of hepatitis B in a hemodialysis unit
53. Hepatitis-B antigen on environmental surfaces
54. Hemodialysis-associated hepatitis B: Report of an outbreak
55. Effect of multiple use of dialyzers on hepatitis B incidence in patients and staff
56. Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects
57. Biochemical evaluation of ultrafiltrate in dialysis-dependent HBsAg-positive patients
58. Nature of HBsAg ultrafiltrate of haemodialysed patients: Presence of viral DNA
59. Hepatitis B viral DNA detectable in dialysate
60. High-flux membranes are not permeable to hepatitis B virus DNA
61. Comparison of four methods for quantitative measurement of hepatitis B viral DNA
62. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis
63. Inactivation of hepatitis B virus by intermediate to high level disinfectant chemicals
64. The effect of the disinfectant AMU2SO vs. hepatitis B virus analyzed using MADT (Morphological alteration and disintegration test)
65. Eradication of biofilm by a procedure including cleaning and autoclavage
66. Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially